NN

Nayanaben Nayankumar Vyas

Active Director Director DIN 09452461
DIN 09452461 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nayanaben Nayankumar Vyas

Data last updated:

Nayanaben Nayankumar Vyas is a Director at Rappel Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09452461
Primary Designation Director
Industry Chemicals
First Appointment 30 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Dec 20212021Active

Board colleagues of Nayanaben Nayankumar Vyas

Directorship timeline

Open interactive timeline →
Rappel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nayanaben Nayankumar Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nayanaben Nayankumar Vyas

Nayanaben Nayankumar Vyas currently holds 1 directorship: Rappel Pharmaceuticals Private Limited (Director, since 30 Dec 2021).

Nayanaben Nayankumar Vyas was first appointed on 30 Dec 2021 as Director at Rappel Pharmaceuticals Private Limited.

The current boards of Nayanaben Nayankumar Vyas's companies include Nayankumar Gordhanbhai Vyas (Rappel Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available